Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for mcl1 protein, human (compound)
Most Correlated Studies
- Breast cancer MDA-MB-468, MDA-MB-231, and MDA-MB-157 cells with thalidomide, BETi-211, or BETd-246
- T cell acute lymphoblastic leukemia cells with JDP2 shRNA knockdown
- Breast adenocarcinoma MDA-MB-468 cells with PRPF8 or PRPF38A siRNA knockdown or treated with E7107
- Lung cancer A549 and Calu-6 cells treated with pimasertib
- Chronic lymphocytic leukemia cells treated with CDKI-73 and fludarabine
Most Relevant Literature
- GSK3β suppression inhibits MCL1 protein synthesis in human acute myeloid leukemia cells.
- The deubiquitinating enzyme USP20 regulates the stability of the MCL1 protein.
- β2-adrenoreceptor Signaling Increases Therapy Resistance in Prostate Cancer by Upregulating MCL1.
- Structural revision of the Mcl-1 inhibitor MIM1: synthesis and biological studies on ovarian cancer …
- Saga of Mcl-1: regulation from transcription to degradation.
Most Relevant Clinical Trials
- AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Partic…
- VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed…
- Study of the Metabolism in the Lymphatic Niche of CLL
- Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometri…
- Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapse…
